Jane Street’s Pharming Group PHAR Stock Holding History

Jane Street’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,441	Closed	-$164K	–	10641
2021 Q3	$164K	Buy	17,441 +4,767	+38%	+$50.5K	﹤0.01%	8995
2021 Q2	$144K	Buy	+12,674	New	+$158K	﹤0.01%	9067

Other funds holding PHAR

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's PHAR Position: Q4 2021 in Review

Jane Street sold out of Pharming Group (PHAR) in Q4 2021, closing a stake of 17,441 shares — an estimated $164K sold.

Jane Street first reported a position in PHAR in Q2 2021 and held it in 2 quarters. The position peaked at $164K in Q3 2021. 3 funds tracked by Wall St. Rank hold PHAR as of Q4 2021.

Jane Street reported no remaining Pharming Group position as of Q4 2021 after selling out during the quarter.
Jane Street sold 17,441 Pharming Group shares in Q4 2021, an estimated $164K.
Jane Street first reported a position in Pharming Group in Q2 2021 and held it in 2 quarters.
Jane Street's Pharming Group position peaked at $164K in Q3 2021.
3 funds tracked by Wall St. Rank held Pharming Group as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.